May 6, 2026  — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions, LLC, announced a strategic partnership to deliver fully integrated cardiac safety monitoring and imaging services to pharmaceutical and biotechnology sponsors worldwide.

computed tomography, angiography, patient transport

The clinical case for combining CT and angiography in a single workflow has been settled. Purpose-built mobile imaging systems have already demonstrated it: when an interventional team can move between CT guidance and angiographic intervention without relocating the patient, outcomes improve. Stroke treatment accelerates. Hemorrhagic trauma management improves. Minimally invasive oncology procedures that once required two separate room visits can be completed in one encounter.

May 4, 2026 — Johnson & Johnson recently announced new data from a novel U.S. pilot single-arm trial that evaluated the safety and feasibility of planned Impella 5.5 support in adult patients undergoing cardiac surgery in the setting of severe left ventricular dysfunction. 

May 4, 2026 — A new guideline from the American Society of Echocardiography (ASE) provides guidance for cardiovascular ultrasound imaging professionals to better recognize and understand cardiac ultrasound artifacts, aiming to enhance diagnostic accuracy and patient safety.

myocardial infarction, heart attack, immune system

Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the aftereffects? Those were the questions researchers at the University of California, San Diego (UCSD) recently sought to answer. The study’s outcomes, published in February, could change the traditional view of heart attacks as solely a structural problem inside the heart, potentially leading to new therapies and multidisciplinary treatment approaches.

April 29, 2026 — Agitated Solutions, Inc.(ASI) has received CE Mark approval in the European Union for its novel device, the Orbis Microbubble Generator, confirming the device meets the high safety, health, and environmental protection requirements necessary to market in the EU.

angiography, PCI, FFRangio

Editor's Note: This is Part Two of a three-part series highlighting several of the presentations from the American College of Cardiology’s Annual Scientific Session (ACC.26) that took place in March in New Orleans, Louisiana.

 

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next-generation Ultreon 3.0 software. This marks a major step forward as it brings coronary imaging and AI-automated insights together in one system to support better patient outcomes and help reduce risks.

April 26, 2026 — New results from the multicenter catheter ablation versus anti-arrhythmic drugs for Ventricular Tachycardia (CAAD-VT) trial show that catheter ablation may reduce ventricular tachycardia (VT) events in patients with ischemic and non-ischemic cardiomyopathy. Researchers presented these findings as a late-breaking clinical trial at Heart Rhythm 2026 in Chicago.  

April 24, 2026 — University of Texas Health Science Center at Houston (UTHealth Houston) has established the Department of Cardiology at McGovern Medical School, marking a significant milestone in the university’s efforts to advance cardiovascular care, research and education across the region.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now